Navigation Links
Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen
Date:11/28/2011

DES PLAINES, Ill., Nov. 28, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it will expand its existing agreement with GlaxoSmithKline Biologicals S.A. (GSK) to include the development of an additional companion diagnostic test in support of GSK's cancer immunotherapy research program. Companion diagnostic tests are designed to identify specific DNA sequences to help guide physicians in determining which patients are more or less likely to benefit from a particular therapy.

The existing agreements between the two companies, announced in July 2009 and March 2010, focused on the development of PCR (polymerase chain reaction) tests to screen non-small cell lung cancer and melanoma tumors for expression of the MAGE-A3 antigen. Under the expanded agreement, Abbott will develop a PCR test for use on the Abbott m2000rt™ instrument to screen non-small cell lung cancer tumors for the expression of the PRAME antigen. PRAME is a preferentially expressed antigen of melanoma that is expressed in 69 percent of non-small cell lung cancer cases, as well as in a wide variety of cancer types, including melanoma, breast, ovarian, and bladder cancer, with limited expression in normal cells.

"This expanded collaboration, along with Abbott's other recently announced partnerships in oncology, demonstrates the continued commitment Abbott is making to assess biomarkers linked to immunotherapies in various cancers," said Stafford O'Kelly, head of Abbott's molecular diagnostics business. "This agreement is a testament to the scientific advances Abbott and the industry is making in personalized medicine and companion diagnostics, which are helping ensure the right medicines get to the right cancer patients."

Molecular Tests for Oncology
Abbott's development efforts in areas such as MAGE-A3 and PRAME will further build its leadership position in cancer diagnostics and personalized medicine. Abbott is a pioneer in the use of mo
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
2. Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
3. PATH, Abbott and the Abbott Fund Form Innovative Partnership to Prevent Malnutrition
4. Perrigo Confirms Filing for Testosterone Gel 1.0% and Announcement of Patent Infringement Lawsuit by Abbott
5. Experts Report that Abbotts New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense
6. Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees
7. Abbotts Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
8. Abbott Honored With Asian CSR Award for Leadership in Science Education
9. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
10. Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals
11. Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "China Orthopedic Instrument Industry Report, 2014-2017" report ... aging population and rising proportion of reimbursement for medical ... effectively released, with its scale presenting a CAGR of ... products are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... , ... Netherlands , January 12 QIAGEN N.V.,(NASDAQ: QGEN ; ... GmbH, a privately held developer and manufacturer of UV and,fluorescence optical measurement ... at up to US$19 million in cash. , ...
... , MINNEAPOLIS, Jan. 11 ATS Medical, Inc. (Nasdaq: ... and services today announced preliminary fourth quarter 2009 revenue and ... Medical,s President and Chief Executive Officer, Michael Dale, at the ... 2010, in San Francisco, CA, at 8 a.m. Pacific Time ...
Cached Medicine Technology:QIAGEN Acquires ESE GmbH 2QIAGEN Acquires ESE GmbH 3QIAGEN Acquires ESE GmbH 4QIAGEN Acquires ESE GmbH 5QIAGEN Acquires ESE GmbH 6QIAGEN Acquires ESE GmbH 7ATS Medical Announces Preliminary Fourth Quarter 2009 Results 2ATS Medical Announces Preliminary Fourth Quarter 2009 Results 3ATS Medical Announces Preliminary Fourth Quarter 2009 Results 4
(Date:8/29/2014)... Indosoft, Inc., a leading provider of scalable Asterisk-based ... licensing of its Q-Suite 5.7 software. As a ... been successfully deploying and supporting its ACD and Dialer ... the world for more than a decade. The introduction ... option which complements the widespread deployment of Q-Suite in ...
(Date:8/29/2014)... 30, 2014 Developed as a nod ... quality Canada Goose products offer the mobility, ... on Arctic runways. The company’s Canada Goose Chilliwack ... the current market. Additionally, the firm has unveiled its ... , At present, all high quality Chilliwack bombers ...
(Date:8/29/2014)... 29, 2014 As reported by GantDaily.com in ... Drug Abuse Trends , Outbreaks (8/20), the National Institute on ... monitor drug abuse trends by turning to social media. As ... trends, it is also working with the University of Maryland ... Early Warning System, which will be funded by the National ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Formed in 2014, ... talents well beyond their years. Their sophisticated Pop/R&B sound, ... music listener is fortunate enough to experience every day. ... their audience uplifted and feeling loved with the primary purpose ... specifically about this, the group unanimously replied - “To make ...
(Date:8/29/2014)... California (PRWEB) August 29, 2014 ... to Chapman University Physical Therapy students via Clinical ... Chapman University will be shadowing Healthpointe providers and ... allow them to develop clinical experience and learn ... Therapy students will gain insight into several patient ...
Breaking Medicine News(10 mins):Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2
... viruses due to their protective protein cover which protects them. ... //. ,Tackling this problem, scientists at the Institut ... the European Molecular Biology Laboratory (EMBL) in Grenoble have found ... a protein that allows the rabies virus to be harmful ...
... Australian beauty with roots in India open to acting in ... in India// who will represent Australia in the Miss World ... ,The first person of non-Australian parentage to win the ... an Indian mother and a Lebanese father. ,Sabrina, ...
... of Union Health Minister Anbumani Ramdoss, a pro-reservation ... P Venugopal and some senior doctors for allegedly ... Delhi against reservations for OBCs in higher education. ... members of the institution instigated the anti-quota protests ...
... According to a finding published in the medical journal Pediatrics, ... to guard// against chicken pox spurt in schools. ,Dr. ... Health conducted a study during an outbreak of chicken pox ... the 545 children attending the school had not suffered chicken ...
... in place of regular salt in everyday diet could ... , high blood pressure and diabetes, a study has ... Institutes in Taiwan and fellow researchers studied nearly 2,000 ... ,The researchers asked cooks at the retirement home to ...
... Swaraj today expressed concern over the turf war between Union ... saying it could "destroy the premier institution". ,"I am ... institution is being destroyed by the present union minister," she ... are working there and it is churning out the best ...
Cached Medicine News:
... QC 463 is a quality control ... monitoring the performance of blood gas, electrolyte, ... practical alternative to the use of human ... in three (3) levels for monitoring analyzer ...
Molteno3 Glaucoma Drainage Device incorporates the latest advances from Professor Moltenos glaucoma research. It has been extensively tested since early 2004 and gives even better control of intraocu...
... way to capture and process ultrasound images, ... a revolutionary advancement. The z.one platform, powered ... Convertible Ultrasound system, instantly converting from a ... ultrasound system with all the performance of ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Medicine Products: